Jagjit Takhar

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, Shruti Singh, 2020, The Lancet.

Is it possible to implement a rare disease case-finding tool in primary care? A UK-based pilot study

S. Shankar, L. Menzies, P.K. Ravichandran, 2021, Orphanet Journal of Rare Diseases.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, L. Lovat, 2020, The Lancet.